Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2(+ )and decreased levels of IL23R(+ )CD4(+ )T - Lymphocytes in multiple sclerosis

BACKGROUND: There are a lack of biomarkers which can be used to predict clinical outcomes for multiple sclerosis (MS) patients receiving interferon beta (IFN-β). Thus the objective of this study was to characterize changes in CD4+ T-lymphocyte expression in an unbiased manner following initiation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kress-Bennett, Jennifer M, Ehrlich, Garth D, Bruno, Ashley, Post, J Christopher, Hu, Fen Z, Scott, Thomas F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292517/
https://www.ncbi.nlm.nih.gov/pubmed/22182694
http://dx.doi.org/10.1186/1471-2377-11-155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292517/
https://www.ncbi.nlm.nih.gov/pubmed/22182694
http://dx.doi.org/10.1186/1471-2377-11-155

Ejemplares similares